Glutaminergic Agents for Cocaine Abuse - 5

Yale University

Status and phase: Completed; Phase 1

Conditions: Cocaine-Related Disorders

Treatments: Drug: Nimodipine

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000280

NIDA-09250-5

P50DA009250 (U.S. NIH Grant/Contract)

P50-09250-5

Details and patient eligibility

About

The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.